June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Complement Factor Y402H polymorphism is not associated with Stargardt’s Disease in Italian Patients
Author Affiliations & Notes
  • Andrea Sodi
    Department Of Specialistic Surgical Sciences, Eye Clinic AOU Careggi, University Of Florence, Firenze, Italy
  • Ilaria Passerini
    Department of Genetic Diagnosis, Azienda Ospedaliero Universitaria Careggi, Firenze, Italy
  • Vittoria Murro
    Department Of Specialistic Surgical Sciences, Eye Clinic AOU Careggi, University Of Florence, Firenze, Italy
  • Luca Boni
    Department of Oncology, Azienda Ospedaliero Universitaria Careggi, Firenze, Italy
  • Giacomo Abbruzzese
    Department Of Specialistic Surgical Sciences, Eye Clinic AOU Careggi, University Of Florence, Firenze, Italy
  • Alba Miele
    Department Of Specialistic Surgical Sciences, Eye Clinic AOU Careggi, University Of Florence, Firenze, Italy
  • Matteo Giuntoli
    Department Of Specialistic Surgical Sciences, Eye Clinic AOU Careggi, University Of Florence, Firenze, Italy
  • Giulio Mecocci
    Imperial College, London, United Kingdom
  • Francesca Torricelli
    Department of Genetic Diagnosis, Azienda Ospedaliero Universitaria Careggi, Firenze, Italy
  • Ugo Menchini
    Department Of Specialistic Surgical Sciences, Eye Clinic AOU Careggi, University Of Florence, Firenze, Italy
  • Footnotes
    Commercial Relationships Andrea Sodi, None; Ilaria Passerini, None; Vittoria Murro, None; Luca Boni, None; Giacomo Abbruzzese, None; Alba Miele, None; Matteo Giuntoli, None; Giulio Mecocci, None; Francesca Torricelli, None; Ugo Menchini, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 1328. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Andrea Sodi, Ilaria Passerini, Vittoria Murro, Luca Boni, Giacomo Abbruzzese, Alba Miele, Matteo Giuntoli, Giulio Mecocci, Francesca Torricelli, Ugo Menchini, Genetics; Complement Factor Y402H polymorphism is not associated with Stargardt’s Disease in Italian Patients. Invest. Ophthalmol. Vis. Sci. 2013;54(15):1328.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: As CFH Y402H polymorphisms has been associated with a higher risk of AMD, clinical, physiopathological and genetic affinities between atrophic AMD and STGD may suggest a possible role of CFH abnormalities also in STGD. The possible association of Y402H and STGD has been investigated in Italian patients.

Methods: One-hundred unrelated STGD patients and 116 patients with advanced atrophic AMD were recruited through the Hereditary Retinal Degenerations Referring Center and the Medical Retina Service of the Eye Clinic, University of Florence . The control group consisted of 100 healthy volunteers. Each patient was genotyped for the single nucleotide polymorphism rs1061170 (Y402H) in the CFH gene using Sequencer 3730 DNA Analyzer. Hardy Weinberg equilibrium was tested using the two sided Pearson's chi-squared test with Yates' continuity correction. Genotype frequency distributions between cases and controls were compared by means of chi squared test for heterogeneity. Univariate unconditional logistic regression was used to calculate odds ratios (OR) and 95% confidence intervals (CIs) for the association between genotypes and diseases under investigation. In addition, the multiplicative and additive genetic models were used for the analysis. All statistical analyses were performed using SAS System 9.2.

Results: Among all the three groups of controls, patients with AMD and patients with STGD, the genotype distribution of Y402H1 was in Hardy Weinberg equilibrium (P=0.327, P=0.320 and P=0.450, respectively). The genotype frequency of Y402H1 were different between patients with AMD and controls (P=0.0003). In the additive model CT genotype was associated with approximately 2.5 times higher odds of disease compared with TT genotype, while CC genotype demonstrated a risk of disease about 5 times higher than the reference group (P for trend<0.0001). Similar genotype frequencies of Y402H1 were observed between patients with STGD and controls (P=0.4882). In this case, the estimates of risk were compatible with the multiplicative genetic model, however results did not achieve the statistical significance (P=0.2639).

Conclusions: In Italian patients CFH Y402H genotype is associated with atrrophic AMD but not with Stargardt’s Disease. This result does not support the hypothesis of a complement system dysregulation in the pathogenesis of Stargardt’s Disease.

Keywords: 688 retina • 539 genetics • 696 retinal degenerations: hereditary  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×